Global Contraceptives

Contraceptives Comprehensive Study by Type (Oral Contraceptive Pills, Contraceptive Injectable, Topical Contraceptive Patch), Application (Hospitals, Homecare, Gynecology Centers, Clinics, Ambulatory Surgical Centers (ASC)), Medical Devices (Male Contraceptives Devices (Condoms), Female contraceptive devices (Female Condoms)) Players and Region - Global Market Outlook to 2026

Contraceptives Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 7.4%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Contraceptives Market Scope
Contraceptives are the drugs or devices which not only inhibit pregnancy but also sexually transmitted diseases (STDs). In addition to this, contraception is deliberate prevention of pregnancy by interfering with the normal process of ovulation, fertilization and implantation through the use of barriers, drugs, medical devices or surgical techniques. The substantial increase in the investments in print advertisements and digital advertisements is significantly contributing to the growth of the very market in the current scenario. Apart from this, favorable initiatives taken by the government to promote awareness regarding unintended pregnancies and growing population in various countries can emerge out as a major opportunity for the expansion of the contraceptive market in the near future.

According to AMA, the Global Contraceptives market is expected to see growth rate of 7.4% and may see market size of USD45.01 Billion by 2026.

Research Analyst at AMA estimates that United States and Indian Players will contribute to the maximum growth of Global Contraceptives market throughout the predicted period.

Merck & Co. (United States), Cipla Inc. (India), Allergan Plc. (Ireland), Bayer AG (Germany), GlaxoSmithKline Plc. (United Kingdom), HLL Lifecare Limited (India), Mankind Pharma (India), Pfizer Inc. (United States), Amgen (United States), Teva Pharmaceutical Industries (Israel), Mithra Pharmaceuticals (Belgium) and Johnson & Johnson (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Glenmark Pharmaceuticals (India), Lupin Pharmaceuticals Inc. (India), Sun Pharmaceutical Industries Ltd. (India) and Piramal Healthcare Limited (India).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
The study have segmented the market of Global Contraceptives market by Type (Oral Contraceptive Pills, Contraceptive Injectable and Topical Contraceptive Patch), by Application (Hospitals, Homecare, Gynecology Centers, Clinics and Ambulatory Surgical Centers (ASC)) and Region with country level break-up.

On the basis of geography, the market of Contraceptives has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Market Trend
  • Increasingly Causing Working Class Women to Postpone Pregnancy in Both Developed and Developing Economies

Market Drivers
  • Rise in Menstruating Population Worldwide, and Encouragement by Government to Use Contraceptives.
  • Increasing Usage Among the Teenagers and Early Maturity Among the Teenage Girls

Opportunities
  • Rising Numbers of New HIV Infections Patients Across the Globe
  • Increasing User Awareness

Restraints
  • The Side Effects Associated with the Use of Contraceptive Drugs and Devices

Challenges
  • Rising Prevalence of Infertility


Key Target Audience
Contraceptives Product Manufacturers, Distributors/Suppliers, Raw Material Suppliers, Retailers/Wholesalers, Government and Research Organizations, End Users and Others

Report Objectives / Segmentation Covered

By Type
  • Oral Contraceptive Pills
  • Contraceptive Injectable
  • Topical Contraceptive Patch
By Application
  • Hospitals
  • Homecare
  • Gynecology Centers
  • Clinics
  • Ambulatory Surgical Centers (ASC)
By Medical Devices
  • Male Contraceptives Devices (Condoms)
  • Female contraceptive devices (Female Condoms)

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in Menstruating Population Worldwide, and Encouragement by Government to Use Contraceptives.
      • 3.2.2. Increasing Usage Among the Teenagers and Early Maturity Among the Teenage Girls
    • 3.3. Market Challenges
      • 3.3.1. Rising Prevalence of Infertility
    • 3.4. Market Trends
      • 3.4.1. Increasingly Causing Working Class Women to Postpone Pregnancy in Both Developed and Developing Economies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Contraceptives, by Type, Application, Medical Devices and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Contraceptives (Value)
      • 5.2.1. Global Contraceptives by: Type (Value)
        • 5.2.1.1. Oral Contraceptive Pills
        • 5.2.1.2. Contraceptive Injectable
        • 5.2.1.3. Topical Contraceptive Patch
      • 5.2.2. Global Contraceptives by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Homecare
        • 5.2.2.3. Gynecology Centers
        • 5.2.2.4. Clinics
        • 5.2.2.5. Ambulatory Surgical Centers (ASC)
      • 5.2.3. Global Contraceptives by: Medical Devices (Value)
        • 5.2.3.1. Male Contraceptives Devices (Condoms)
        • 5.2.3.2. Female contraceptive devices (Female Condoms)
      • 5.2.4. Global Contraceptives Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Contraceptives (Volume)
      • 5.3.1. Global Contraceptives by: Type (Volume)
        • 5.3.1.1. Oral Contraceptive Pills
        • 5.3.1.2. Contraceptive Injectable
        • 5.3.1.3. Topical Contraceptive Patch
      • 5.3.2. Global Contraceptives by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Homecare
        • 5.3.2.3. Gynecology Centers
        • 5.3.2.4. Clinics
        • 5.3.2.5. Ambulatory Surgical Centers (ASC)
      • 5.3.3. Global Contraceptives by: Medical Devices (Volume)
        • 5.3.3.1. Male Contraceptives Devices (Condoms)
        • 5.3.3.2. Female contraceptive devices (Female Condoms)
      • 5.3.4. Global Contraceptives Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Contraceptives (Price)
      • 5.4.1. Global Contraceptives by: Type (Price)
  • 6. Contraceptives: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck & Co. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Cipla Inc. (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Allergan Plc. (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Bayer AG (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. GlaxoSmithKline Plc. (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. HLL Lifecare Limited (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Mankind Pharma (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Pfizer Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Amgen (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Teva Pharmaceutical Industries (Israel)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Mithra Pharmaceuticals (Belgium)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Johnson & Johnson (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Contraceptives Sale, by Type, Application, Medical Devices and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Contraceptives (Value)
      • 7.2.1. Global Contraceptives by: Type (Value)
        • 7.2.1.1. Oral Contraceptive Pills
        • 7.2.1.2. Contraceptive Injectable
        • 7.2.1.3. Topical Contraceptive Patch
      • 7.2.2. Global Contraceptives by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Homecare
        • 7.2.2.3. Gynecology Centers
        • 7.2.2.4. Clinics
        • 7.2.2.5. Ambulatory Surgical Centers (ASC)
      • 7.2.3. Global Contraceptives by: Medical Devices (Value)
        • 7.2.3.1. Male Contraceptives Devices (Condoms)
        • 7.2.3.2. Female contraceptive devices (Female Condoms)
      • 7.2.4. Global Contraceptives Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Contraceptives (Volume)
      • 7.3.1. Global Contraceptives by: Type (Volume)
        • 7.3.1.1. Oral Contraceptive Pills
        • 7.3.1.2. Contraceptive Injectable
        • 7.3.1.3. Topical Contraceptive Patch
      • 7.3.2. Global Contraceptives by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Homecare
        • 7.3.2.3. Gynecology Centers
        • 7.3.2.4. Clinics
        • 7.3.2.5. Ambulatory Surgical Centers (ASC)
      • 7.3.3. Global Contraceptives by: Medical Devices (Volume)
        • 7.3.3.1. Male Contraceptives Devices (Condoms)
        • 7.3.3.2. Female contraceptive devices (Female Condoms)
      • 7.3.4. Global Contraceptives Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Contraceptives (Price)
      • 7.4.1. Global Contraceptives by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Contraceptives: by Type(USD Billion)
  • Table 2. Contraceptives Oral Contraceptive Pills , by Region USD Billion (2015-2020)
  • Table 3. Contraceptives Contraceptive Injectable , by Region USD Billion (2015-2020)
  • Table 4. Contraceptives Topical Contraceptive Patch , by Region USD Billion (2015-2020)
  • Table 5. Contraceptives: by Application(USD Billion)
  • Table 6. Contraceptives Hospitals , by Region USD Billion (2015-2020)
  • Table 7. Contraceptives Homecare , by Region USD Billion (2015-2020)
  • Table 8. Contraceptives Gynecology Centers , by Region USD Billion (2015-2020)
  • Table 9. Contraceptives Clinics , by Region USD Billion (2015-2020)
  • Table 10. Contraceptives Ambulatory Surgical Centers (ASC) , by Region USD Billion (2015-2020)
  • Table 11. Contraceptives: by Medical Devices(USD Billion)
  • Table 12. Contraceptives Male Contraceptives Devices (Condoms) , by Region USD Billion (2015-2020)
  • Table 13. Contraceptives Female contraceptive devices (Female Condoms) , by Region USD Billion (2015-2020)
  • Table 14. South America Contraceptives, by Country USD Billion (2015-2020)
  • Table 15. South America Contraceptives, by Type USD Billion (2015-2020)
  • Table 16. South America Contraceptives, by Application USD Billion (2015-2020)
  • Table 17. South America Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 18. Brazil Contraceptives, by Type USD Billion (2015-2020)
  • Table 19. Brazil Contraceptives, by Application USD Billion (2015-2020)
  • Table 20. Brazil Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 21. Argentina Contraceptives, by Type USD Billion (2015-2020)
  • Table 22. Argentina Contraceptives, by Application USD Billion (2015-2020)
  • Table 23. Argentina Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 24. Rest of South America Contraceptives, by Type USD Billion (2015-2020)
  • Table 25. Rest of South America Contraceptives, by Application USD Billion (2015-2020)
  • Table 26. Rest of South America Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 27. Asia Pacific Contraceptives, by Country USD Billion (2015-2020)
  • Table 28. Asia Pacific Contraceptives, by Type USD Billion (2015-2020)
  • Table 29. Asia Pacific Contraceptives, by Application USD Billion (2015-2020)
  • Table 30. Asia Pacific Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 31. China Contraceptives, by Type USD Billion (2015-2020)
  • Table 32. China Contraceptives, by Application USD Billion (2015-2020)
  • Table 33. China Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 34. Japan Contraceptives, by Type USD Billion (2015-2020)
  • Table 35. Japan Contraceptives, by Application USD Billion (2015-2020)
  • Table 36. Japan Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 37. India Contraceptives, by Type USD Billion (2015-2020)
  • Table 38. India Contraceptives, by Application USD Billion (2015-2020)
  • Table 39. India Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 40. South Korea Contraceptives, by Type USD Billion (2015-2020)
  • Table 41. South Korea Contraceptives, by Application USD Billion (2015-2020)
  • Table 42. South Korea Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 43. Taiwan Contraceptives, by Type USD Billion (2015-2020)
  • Table 44. Taiwan Contraceptives, by Application USD Billion (2015-2020)
  • Table 45. Taiwan Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 46. Australia Contraceptives, by Type USD Billion (2015-2020)
  • Table 47. Australia Contraceptives, by Application USD Billion (2015-2020)
  • Table 48. Australia Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 49. Rest of Asia-Pacific Contraceptives, by Type USD Billion (2015-2020)
  • Table 50. Rest of Asia-Pacific Contraceptives, by Application USD Billion (2015-2020)
  • Table 51. Rest of Asia-Pacific Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 52. Europe Contraceptives, by Country USD Billion (2015-2020)
  • Table 53. Europe Contraceptives, by Type USD Billion (2015-2020)
  • Table 54. Europe Contraceptives, by Application USD Billion (2015-2020)
  • Table 55. Europe Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 56. Germany Contraceptives, by Type USD Billion (2015-2020)
  • Table 57. Germany Contraceptives, by Application USD Billion (2015-2020)
  • Table 58. Germany Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 59. France Contraceptives, by Type USD Billion (2015-2020)
  • Table 60. France Contraceptives, by Application USD Billion (2015-2020)
  • Table 61. France Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 62. Italy Contraceptives, by Type USD Billion (2015-2020)
  • Table 63. Italy Contraceptives, by Application USD Billion (2015-2020)
  • Table 64. Italy Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 65. United Kingdom Contraceptives, by Type USD Billion (2015-2020)
  • Table 66. United Kingdom Contraceptives, by Application USD Billion (2015-2020)
  • Table 67. United Kingdom Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 68. Netherlands Contraceptives, by Type USD Billion (2015-2020)
  • Table 69. Netherlands Contraceptives, by Application USD Billion (2015-2020)
  • Table 70. Netherlands Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 71. Rest of Europe Contraceptives, by Type USD Billion (2015-2020)
  • Table 72. Rest of Europe Contraceptives, by Application USD Billion (2015-2020)
  • Table 73. Rest of Europe Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 74. MEA Contraceptives, by Country USD Billion (2015-2020)
  • Table 75. MEA Contraceptives, by Type USD Billion (2015-2020)
  • Table 76. MEA Contraceptives, by Application USD Billion (2015-2020)
  • Table 77. MEA Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 78. Middle East Contraceptives, by Type USD Billion (2015-2020)
  • Table 79. Middle East Contraceptives, by Application USD Billion (2015-2020)
  • Table 80. Middle East Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 81. Africa Contraceptives, by Type USD Billion (2015-2020)
  • Table 82. Africa Contraceptives, by Application USD Billion (2015-2020)
  • Table 83. Africa Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 84. North America Contraceptives, by Country USD Billion (2015-2020)
  • Table 85. North America Contraceptives, by Type USD Billion (2015-2020)
  • Table 86. North America Contraceptives, by Application USD Billion (2015-2020)
  • Table 87. North America Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 88. United States Contraceptives, by Type USD Billion (2015-2020)
  • Table 89. United States Contraceptives, by Application USD Billion (2015-2020)
  • Table 90. United States Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 91. Canada Contraceptives, by Type USD Billion (2015-2020)
  • Table 92. Canada Contraceptives, by Application USD Billion (2015-2020)
  • Table 93. Canada Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 94. Mexico Contraceptives, by Type USD Billion (2015-2020)
  • Table 95. Mexico Contraceptives, by Application USD Billion (2015-2020)
  • Table 96. Mexico Contraceptives, by Medical Devices USD Billion (2015-2020)
  • Table 97. Contraceptives Sales: by Type(Units)
  • Table 98. Contraceptives Sales Oral Contraceptive Pills , by Region Units (2015-2020)
  • Table 99. Contraceptives Sales Contraceptive Injectable , by Region Units (2015-2020)
  • Table 100. Contraceptives Sales Topical Contraceptive Patch , by Region Units (2015-2020)
  • Table 101. Contraceptives Sales: by Application(Units)
  • Table 102. Contraceptives Sales Hospitals , by Region Units (2015-2020)
  • Table 103. Contraceptives Sales Homecare , by Region Units (2015-2020)
  • Table 104. Contraceptives Sales Gynecology Centers , by Region Units (2015-2020)
  • Table 105. Contraceptives Sales Clinics , by Region Units (2015-2020)
  • Table 106. Contraceptives Sales Ambulatory Surgical Centers (ASC) , by Region Units (2015-2020)
  • Table 107. Contraceptives Sales: by Medical Devices(Units)
  • Table 108. Contraceptives Sales Male Contraceptives Devices (Condoms) , by Region Units (2015-2020)
  • Table 109. Contraceptives Sales Female contraceptive devices (Female Condoms) , by Region Units (2015-2020)
  • Table 110. South America Contraceptives Sales, by Country Units (2015-2020)
  • Table 111. South America Contraceptives Sales, by Type Units (2015-2020)
  • Table 112. South America Contraceptives Sales, by Application Units (2015-2020)
  • Table 113. South America Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 114. Brazil Contraceptives Sales, by Type Units (2015-2020)
  • Table 115. Brazil Contraceptives Sales, by Application Units (2015-2020)
  • Table 116. Brazil Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 117. Argentina Contraceptives Sales, by Type Units (2015-2020)
  • Table 118. Argentina Contraceptives Sales, by Application Units (2015-2020)
  • Table 119. Argentina Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 120. Rest of South America Contraceptives Sales, by Type Units (2015-2020)
  • Table 121. Rest of South America Contraceptives Sales, by Application Units (2015-2020)
  • Table 122. Rest of South America Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 123. Asia Pacific Contraceptives Sales, by Country Units (2015-2020)
  • Table 124. Asia Pacific Contraceptives Sales, by Type Units (2015-2020)
  • Table 125. Asia Pacific Contraceptives Sales, by Application Units (2015-2020)
  • Table 126. Asia Pacific Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 127. China Contraceptives Sales, by Type Units (2015-2020)
  • Table 128. China Contraceptives Sales, by Application Units (2015-2020)
  • Table 129. China Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 130. Japan Contraceptives Sales, by Type Units (2015-2020)
  • Table 131. Japan Contraceptives Sales, by Application Units (2015-2020)
  • Table 132. Japan Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 133. India Contraceptives Sales, by Type Units (2015-2020)
  • Table 134. India Contraceptives Sales, by Application Units (2015-2020)
  • Table 135. India Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 136. South Korea Contraceptives Sales, by Type Units (2015-2020)
  • Table 137. South Korea Contraceptives Sales, by Application Units (2015-2020)
  • Table 138. South Korea Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 139. Taiwan Contraceptives Sales, by Type Units (2015-2020)
  • Table 140. Taiwan Contraceptives Sales, by Application Units (2015-2020)
  • Table 141. Taiwan Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 142. Australia Contraceptives Sales, by Type Units (2015-2020)
  • Table 143. Australia Contraceptives Sales, by Application Units (2015-2020)
  • Table 144. Australia Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 145. Rest of Asia-Pacific Contraceptives Sales, by Type Units (2015-2020)
  • Table 146. Rest of Asia-Pacific Contraceptives Sales, by Application Units (2015-2020)
  • Table 147. Rest of Asia-Pacific Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 148. Europe Contraceptives Sales, by Country Units (2015-2020)
  • Table 149. Europe Contraceptives Sales, by Type Units (2015-2020)
  • Table 150. Europe Contraceptives Sales, by Application Units (2015-2020)
  • Table 151. Europe Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 152. Germany Contraceptives Sales, by Type Units (2015-2020)
  • Table 153. Germany Contraceptives Sales, by Application Units (2015-2020)
  • Table 154. Germany Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 155. France Contraceptives Sales, by Type Units (2015-2020)
  • Table 156. France Contraceptives Sales, by Application Units (2015-2020)
  • Table 157. France Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 158. Italy Contraceptives Sales, by Type Units (2015-2020)
  • Table 159. Italy Contraceptives Sales, by Application Units (2015-2020)
  • Table 160. Italy Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 161. United Kingdom Contraceptives Sales, by Type Units (2015-2020)
  • Table 162. United Kingdom Contraceptives Sales, by Application Units (2015-2020)
  • Table 163. United Kingdom Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 164. Netherlands Contraceptives Sales, by Type Units (2015-2020)
  • Table 165. Netherlands Contraceptives Sales, by Application Units (2015-2020)
  • Table 166. Netherlands Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 167. Rest of Europe Contraceptives Sales, by Type Units (2015-2020)
  • Table 168. Rest of Europe Contraceptives Sales, by Application Units (2015-2020)
  • Table 169. Rest of Europe Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 170. MEA Contraceptives Sales, by Country Units (2015-2020)
  • Table 171. MEA Contraceptives Sales, by Type Units (2015-2020)
  • Table 172. MEA Contraceptives Sales, by Application Units (2015-2020)
  • Table 173. MEA Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 174. Middle East Contraceptives Sales, by Type Units (2015-2020)
  • Table 175. Middle East Contraceptives Sales, by Application Units (2015-2020)
  • Table 176. Middle East Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 177. Africa Contraceptives Sales, by Type Units (2015-2020)
  • Table 178. Africa Contraceptives Sales, by Application Units (2015-2020)
  • Table 179. Africa Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 180. North America Contraceptives Sales, by Country Units (2015-2020)
  • Table 181. North America Contraceptives Sales, by Type Units (2015-2020)
  • Table 182. North America Contraceptives Sales, by Application Units (2015-2020)
  • Table 183. North America Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 184. United States Contraceptives Sales, by Type Units (2015-2020)
  • Table 185. United States Contraceptives Sales, by Application Units (2015-2020)
  • Table 186. United States Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 187. Canada Contraceptives Sales, by Type Units (2015-2020)
  • Table 188. Canada Contraceptives Sales, by Application Units (2015-2020)
  • Table 189. Canada Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 190. Mexico Contraceptives Sales, by Type Units (2015-2020)
  • Table 191. Mexico Contraceptives Sales, by Application Units (2015-2020)
  • Table 192. Mexico Contraceptives Sales, by Medical Devices Units (2015-2020)
  • Table 193. Contraceptives: by Type(USD/Units)
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Contraceptives: by Type(USD Billion)
  • Table 207. Contraceptives Oral Contraceptive Pills , by Region USD Billion (2021-2026)
  • Table 208. Contraceptives Contraceptive Injectable , by Region USD Billion (2021-2026)
  • Table 209. Contraceptives Topical Contraceptive Patch , by Region USD Billion (2021-2026)
  • Table 210. Contraceptives: by Application(USD Billion)
  • Table 211. Contraceptives Hospitals , by Region USD Billion (2021-2026)
  • Table 212. Contraceptives Homecare , by Region USD Billion (2021-2026)
  • Table 213. Contraceptives Gynecology Centers , by Region USD Billion (2021-2026)
  • Table 214. Contraceptives Clinics , by Region USD Billion (2021-2026)
  • Table 215. Contraceptives Ambulatory Surgical Centers (ASC) , by Region USD Billion (2021-2026)
  • Table 216. Contraceptives: by Medical Devices(USD Billion)
  • Table 217. Contraceptives Male Contraceptives Devices (Condoms) , by Region USD Billion (2021-2026)
  • Table 218. Contraceptives Female contraceptive devices (Female Condoms) , by Region USD Billion (2021-2026)
  • Table 219. South America Contraceptives, by Country USD Billion (2021-2026)
  • Table 220. South America Contraceptives, by Type USD Billion (2021-2026)
  • Table 221. South America Contraceptives, by Application USD Billion (2021-2026)
  • Table 222. South America Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 223. Brazil Contraceptives, by Type USD Billion (2021-2026)
  • Table 224. Brazil Contraceptives, by Application USD Billion (2021-2026)
  • Table 225. Brazil Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 226. Argentina Contraceptives, by Type USD Billion (2021-2026)
  • Table 227. Argentina Contraceptives, by Application USD Billion (2021-2026)
  • Table 228. Argentina Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 229. Rest of South America Contraceptives, by Type USD Billion (2021-2026)
  • Table 230. Rest of South America Contraceptives, by Application USD Billion (2021-2026)
  • Table 231. Rest of South America Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 232. Asia Pacific Contraceptives, by Country USD Billion (2021-2026)
  • Table 233. Asia Pacific Contraceptives, by Type USD Billion (2021-2026)
  • Table 234. Asia Pacific Contraceptives, by Application USD Billion (2021-2026)
  • Table 235. Asia Pacific Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 236. China Contraceptives, by Type USD Billion (2021-2026)
  • Table 237. China Contraceptives, by Application USD Billion (2021-2026)
  • Table 238. China Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 239. Japan Contraceptives, by Type USD Billion (2021-2026)
  • Table 240. Japan Contraceptives, by Application USD Billion (2021-2026)
  • Table 241. Japan Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 242. India Contraceptives, by Type USD Billion (2021-2026)
  • Table 243. India Contraceptives, by Application USD Billion (2021-2026)
  • Table 244. India Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 245. South Korea Contraceptives, by Type USD Billion (2021-2026)
  • Table 246. South Korea Contraceptives, by Application USD Billion (2021-2026)
  • Table 247. South Korea Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 248. Taiwan Contraceptives, by Type USD Billion (2021-2026)
  • Table 249. Taiwan Contraceptives, by Application USD Billion (2021-2026)
  • Table 250. Taiwan Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 251. Australia Contraceptives, by Type USD Billion (2021-2026)
  • Table 252. Australia Contraceptives, by Application USD Billion (2021-2026)
  • Table 253. Australia Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 254. Rest of Asia-Pacific Contraceptives, by Type USD Billion (2021-2026)
  • Table 255. Rest of Asia-Pacific Contraceptives, by Application USD Billion (2021-2026)
  • Table 256. Rest of Asia-Pacific Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 257. Europe Contraceptives, by Country USD Billion (2021-2026)
  • Table 258. Europe Contraceptives, by Type USD Billion (2021-2026)
  • Table 259. Europe Contraceptives, by Application USD Billion (2021-2026)
  • Table 260. Europe Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 261. Germany Contraceptives, by Type USD Billion (2021-2026)
  • Table 262. Germany Contraceptives, by Application USD Billion (2021-2026)
  • Table 263. Germany Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 264. France Contraceptives, by Type USD Billion (2021-2026)
  • Table 265. France Contraceptives, by Application USD Billion (2021-2026)
  • Table 266. France Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 267. Italy Contraceptives, by Type USD Billion (2021-2026)
  • Table 268. Italy Contraceptives, by Application USD Billion (2021-2026)
  • Table 269. Italy Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 270. United Kingdom Contraceptives, by Type USD Billion (2021-2026)
  • Table 271. United Kingdom Contraceptives, by Application USD Billion (2021-2026)
  • Table 272. United Kingdom Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 273. Netherlands Contraceptives, by Type USD Billion (2021-2026)
  • Table 274. Netherlands Contraceptives, by Application USD Billion (2021-2026)
  • Table 275. Netherlands Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 276. Rest of Europe Contraceptives, by Type USD Billion (2021-2026)
  • Table 277. Rest of Europe Contraceptives, by Application USD Billion (2021-2026)
  • Table 278. Rest of Europe Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 279. MEA Contraceptives, by Country USD Billion (2021-2026)
  • Table 280. MEA Contraceptives, by Type USD Billion (2021-2026)
  • Table 281. MEA Contraceptives, by Application USD Billion (2021-2026)
  • Table 282. MEA Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 283. Middle East Contraceptives, by Type USD Billion (2021-2026)
  • Table 284. Middle East Contraceptives, by Application USD Billion (2021-2026)
  • Table 285. Middle East Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 286. Africa Contraceptives, by Type USD Billion (2021-2026)
  • Table 287. Africa Contraceptives, by Application USD Billion (2021-2026)
  • Table 288. Africa Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 289. North America Contraceptives, by Country USD Billion (2021-2026)
  • Table 290. North America Contraceptives, by Type USD Billion (2021-2026)
  • Table 291. North America Contraceptives, by Application USD Billion (2021-2026)
  • Table 292. North America Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 293. United States Contraceptives, by Type USD Billion (2021-2026)
  • Table 294. United States Contraceptives, by Application USD Billion (2021-2026)
  • Table 295. United States Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 296. Canada Contraceptives, by Type USD Billion (2021-2026)
  • Table 297. Canada Contraceptives, by Application USD Billion (2021-2026)
  • Table 298. Canada Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 299. Mexico Contraceptives, by Type USD Billion (2021-2026)
  • Table 300. Mexico Contraceptives, by Application USD Billion (2021-2026)
  • Table 301. Mexico Contraceptives, by Medical Devices USD Billion (2021-2026)
  • Table 302. Contraceptives Sales: by Type(Units)
  • Table 303. Contraceptives Sales Oral Contraceptive Pills , by Region Units (2021-2026)
  • Table 304. Contraceptives Sales Contraceptive Injectable , by Region Units (2021-2026)
  • Table 305. Contraceptives Sales Topical Contraceptive Patch , by Region Units (2021-2026)
  • Table 306. Contraceptives Sales: by Application(Units)
  • Table 307. Contraceptives Sales Hospitals , by Region Units (2021-2026)
  • Table 308. Contraceptives Sales Homecare , by Region Units (2021-2026)
  • Table 309. Contraceptives Sales Gynecology Centers , by Region Units (2021-2026)
  • Table 310. Contraceptives Sales Clinics , by Region Units (2021-2026)
  • Table 311. Contraceptives Sales Ambulatory Surgical Centers (ASC) , by Region Units (2021-2026)
  • Table 312. Contraceptives Sales: by Medical Devices(Units)
  • Table 313. Contraceptives Sales Male Contraceptives Devices (Condoms) , by Region Units (2021-2026)
  • Table 314. Contraceptives Sales Female contraceptive devices (Female Condoms) , by Region Units (2021-2026)
  • Table 315. South America Contraceptives Sales, by Country Units (2021-2026)
  • Table 316. South America Contraceptives Sales, by Type Units (2021-2026)
  • Table 317. South America Contraceptives Sales, by Application Units (2021-2026)
  • Table 318. South America Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 319. Brazil Contraceptives Sales, by Type Units (2021-2026)
  • Table 320. Brazil Contraceptives Sales, by Application Units (2021-2026)
  • Table 321. Brazil Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 322. Argentina Contraceptives Sales, by Type Units (2021-2026)
  • Table 323. Argentina Contraceptives Sales, by Application Units (2021-2026)
  • Table 324. Argentina Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 325. Rest of South America Contraceptives Sales, by Type Units (2021-2026)
  • Table 326. Rest of South America Contraceptives Sales, by Application Units (2021-2026)
  • Table 327. Rest of South America Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 328. Asia Pacific Contraceptives Sales, by Country Units (2021-2026)
  • Table 329. Asia Pacific Contraceptives Sales, by Type Units (2021-2026)
  • Table 330. Asia Pacific Contraceptives Sales, by Application Units (2021-2026)
  • Table 331. Asia Pacific Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 332. China Contraceptives Sales, by Type Units (2021-2026)
  • Table 333. China Contraceptives Sales, by Application Units (2021-2026)
  • Table 334. China Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 335. Japan Contraceptives Sales, by Type Units (2021-2026)
  • Table 336. Japan Contraceptives Sales, by Application Units (2021-2026)
  • Table 337. Japan Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 338. India Contraceptives Sales, by Type Units (2021-2026)
  • Table 339. India Contraceptives Sales, by Application Units (2021-2026)
  • Table 340. India Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 341. South Korea Contraceptives Sales, by Type Units (2021-2026)
  • Table 342. South Korea Contraceptives Sales, by Application Units (2021-2026)
  • Table 343. South Korea Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 344. Taiwan Contraceptives Sales, by Type Units (2021-2026)
  • Table 345. Taiwan Contraceptives Sales, by Application Units (2021-2026)
  • Table 346. Taiwan Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 347. Australia Contraceptives Sales, by Type Units (2021-2026)
  • Table 348. Australia Contraceptives Sales, by Application Units (2021-2026)
  • Table 349. Australia Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 350. Rest of Asia-Pacific Contraceptives Sales, by Type Units (2021-2026)
  • Table 351. Rest of Asia-Pacific Contraceptives Sales, by Application Units (2021-2026)
  • Table 352. Rest of Asia-Pacific Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 353. Europe Contraceptives Sales, by Country Units (2021-2026)
  • Table 354. Europe Contraceptives Sales, by Type Units (2021-2026)
  • Table 355. Europe Contraceptives Sales, by Application Units (2021-2026)
  • Table 356. Europe Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 357. Germany Contraceptives Sales, by Type Units (2021-2026)
  • Table 358. Germany Contraceptives Sales, by Application Units (2021-2026)
  • Table 359. Germany Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 360. France Contraceptives Sales, by Type Units (2021-2026)
  • Table 361. France Contraceptives Sales, by Application Units (2021-2026)
  • Table 362. France Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 363. Italy Contraceptives Sales, by Type Units (2021-2026)
  • Table 364. Italy Contraceptives Sales, by Application Units (2021-2026)
  • Table 365. Italy Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 366. United Kingdom Contraceptives Sales, by Type Units (2021-2026)
  • Table 367. United Kingdom Contraceptives Sales, by Application Units (2021-2026)
  • Table 368. United Kingdom Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 369. Netherlands Contraceptives Sales, by Type Units (2021-2026)
  • Table 370. Netherlands Contraceptives Sales, by Application Units (2021-2026)
  • Table 371. Netherlands Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 372. Rest of Europe Contraceptives Sales, by Type Units (2021-2026)
  • Table 373. Rest of Europe Contraceptives Sales, by Application Units (2021-2026)
  • Table 374. Rest of Europe Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 375. MEA Contraceptives Sales, by Country Units (2021-2026)
  • Table 376. MEA Contraceptives Sales, by Type Units (2021-2026)
  • Table 377. MEA Contraceptives Sales, by Application Units (2021-2026)
  • Table 378. MEA Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 379. Middle East Contraceptives Sales, by Type Units (2021-2026)
  • Table 380. Middle East Contraceptives Sales, by Application Units (2021-2026)
  • Table 381. Middle East Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 382. Africa Contraceptives Sales, by Type Units (2021-2026)
  • Table 383. Africa Contraceptives Sales, by Application Units (2021-2026)
  • Table 384. Africa Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 385. North America Contraceptives Sales, by Country Units (2021-2026)
  • Table 386. North America Contraceptives Sales, by Type Units (2021-2026)
  • Table 387. North America Contraceptives Sales, by Application Units (2021-2026)
  • Table 388. North America Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 389. United States Contraceptives Sales, by Type Units (2021-2026)
  • Table 390. United States Contraceptives Sales, by Application Units (2021-2026)
  • Table 391. United States Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 392. Canada Contraceptives Sales, by Type Units (2021-2026)
  • Table 393. Canada Contraceptives Sales, by Application Units (2021-2026)
  • Table 394. Canada Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 395. Mexico Contraceptives Sales, by Type Units (2021-2026)
  • Table 396. Mexico Contraceptives Sales, by Application Units (2021-2026)
  • Table 397. Mexico Contraceptives Sales, by Medical Devices Units (2021-2026)
  • Table 398. Contraceptives: by Type(USD/Units)
  • Table 399. Research Programs/Design for This Report
  • Table 400. Key Data Information from Secondary Sources
  • Table 401. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Contraceptives: by Type USD Billion (2015-2020)
  • Figure 5. Global Contraceptives: by Application USD Billion (2015-2020)
  • Figure 6. Global Contraceptives: by Medical Devices USD Billion (2015-2020)
  • Figure 7. South America Contraceptives Share (%), by Country
  • Figure 8. Asia Pacific Contraceptives Share (%), by Country
  • Figure 9. Europe Contraceptives Share (%), by Country
  • Figure 10. MEA Contraceptives Share (%), by Country
  • Figure 11. North America Contraceptives Share (%), by Country
  • Figure 12. Global Contraceptives: by Type Units (2015-2020)
  • Figure 13. Global Contraceptives: by Application Units (2015-2020)
  • Figure 14. Global Contraceptives: by Medical Devices Units (2015-2020)
  • Figure 15. South America Contraceptives Share (%), by Country
  • Figure 16. Asia Pacific Contraceptives Share (%), by Country
  • Figure 17. Europe Contraceptives Share (%), by Country
  • Figure 18. MEA Contraceptives Share (%), by Country
  • Figure 19. North America Contraceptives Share (%), by Country
  • Figure 20. Global Contraceptives: by Type USD/Units (2015-2020)
  • Figure 21. Global Contraceptives share by Players 2020 (%)
  • Figure 22. Global Contraceptives share by Players (Top 3) 2020(%)
  • Figure 23. Global Contraceptives share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Merck & Co. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Merck & Co. (United States) Revenue: by Geography 2020
  • Figure 27. Cipla Inc. (India) Revenue, Net Income and Gross profit
  • Figure 28. Cipla Inc. (India) Revenue: by Geography 2020
  • Figure 29. Allergan Plc. (Ireland) Revenue, Net Income and Gross profit
  • Figure 30. Allergan Plc. (Ireland) Revenue: by Geography 2020
  • Figure 31. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Bayer AG (Germany) Revenue: by Geography 2020
  • Figure 33. GlaxoSmithKline Plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. GlaxoSmithKline Plc. (United Kingdom) Revenue: by Geography 2020
  • Figure 35. HLL Lifecare Limited (India) Revenue, Net Income and Gross profit
  • Figure 36. HLL Lifecare Limited (India) Revenue: by Geography 2020
  • Figure 37. Mankind Pharma (India) Revenue, Net Income and Gross profit
  • Figure 38. Mankind Pharma (India) Revenue: by Geography 2020
  • Figure 39. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 41. Amgen (United States) Revenue, Net Income and Gross profit
  • Figure 42. Amgen (United States) Revenue: by Geography 2020
  • Figure 43. Teva Pharmaceutical Industries (Israel) Revenue, Net Income and Gross profit
  • Figure 44. Teva Pharmaceutical Industries (Israel) Revenue: by Geography 2020
  • Figure 45. Mithra Pharmaceuticals (Belgium) Revenue, Net Income and Gross profit
  • Figure 46. Mithra Pharmaceuticals (Belgium) Revenue: by Geography 2020
  • Figure 47. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 48. Johnson & Johnson (United States) Revenue: by Geography 2020
  • Figure 49. Global Contraceptives: by Type USD Billion (2021-2026)
  • Figure 50. Global Contraceptives: by Application USD Billion (2021-2026)
  • Figure 51. Global Contraceptives: by Medical Devices USD Billion (2021-2026)
  • Figure 52. South America Contraceptives Share (%), by Country
  • Figure 53. Asia Pacific Contraceptives Share (%), by Country
  • Figure 54. Europe Contraceptives Share (%), by Country
  • Figure 55. MEA Contraceptives Share (%), by Country
  • Figure 56. North America Contraceptives Share (%), by Country
  • Figure 57. Global Contraceptives: by Type Units (2021-2026)
  • Figure 58. Global Contraceptives: by Application Units (2021-2026)
  • Figure 59. Global Contraceptives: by Medical Devices Units (2021-2026)
  • Figure 60. South America Contraceptives Share (%), by Country
  • Figure 61. Asia Pacific Contraceptives Share (%), by Country
  • Figure 62. Europe Contraceptives Share (%), by Country
  • Figure 63. MEA Contraceptives Share (%), by Country
  • Figure 64. North America Contraceptives Share (%), by Country
  • Figure 65. Global Contraceptives: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Merck & Co. (United States)
  • Cipla Inc. (India)
  • Allergan Plc. (Ireland)
  • Bayer AG (Germany)
  • GlaxoSmithKline Plc. (United Kingdom)
  • HLL Lifecare Limited (India)
  • Mankind Pharma (India)
  • Pfizer Inc. (United States)
  • Amgen (United States)
  • Teva Pharmaceutical Industries (Israel)
  • Mithra Pharmaceuticals (Belgium)
  • Johnson & Johnson (United States)
Additional players considered in the study are as follows:
Glenmark Pharmaceuticals (India) , Lupin Pharmaceuticals Inc. (India) , Sun Pharmaceutical Industries Ltd. (India) , Piramal Healthcare Limited (India)
Select User Access Type

Key Highlights of Report


Jan 2022 222 Pages 54 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Contraceptives Quantitative research analysis
Global Contraceptives Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Contraceptives study can be customized to meet your requirements. The market size breakdown by type [Oral Contraceptive Pills, Contraceptive Injectable and Topical Contraceptive Patch], by end use application [Hospitals, Homecare, Gynecology Centers, Clinics and Ambulatory Surgical Centers (ASC)].
The Contraceptives Market is gaining popularity and expected to see strong valuation by 2026.
According to AMA, the Global Contraceptives market is expected to see growth rate of 7.4%.

Know More About Global Contraceptives Report?

Have a Query? Click Here

Other Related Reports

Encephalitis Vaccine Comprehensive Study by Application (Child, Adult), End User (Hospitals, Clinics, Vaccination Centers, Others), Strain (Nakayama, Beijing, P-3, SA 14-14-2) Players and Region - Gl...
$ 3500
Medical Marijuana Comprehensive Study by Type (Buds, Oil, Tinctures), Application (Chronic Pain, Mental Disorders, Arthritis, Migraine, Cancer, Other), Marijuana Type (Medical Marijuana, Recreational...
$ 3500
Orphan Drugs Comprehensive Study by Drug Type (Biologics, Non-Biologics), Sale (Generics, Prescribed), Drugs (Revlimid, Rituxan, Opdivo, Others), Disease Type (Oncology, Gastrointestinal, Pulmonary, ...
$ 3750
Diptheria Vaccine Comprehensive Study by Type (Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, Quaracel), Disease Type (Diphtheria, Tetanus, Pertussis), Packaging Type (0.5 ML, 1 ML, 2 ML, Others), A...
$ 3450
Bio-pharma Comprehensive Study by Type (Monoclonal Antibodies, Recombinant Proteins, Granulocyte-Colony Stimulating Factor (G-CSF), Interferons, Recombinant Human Insulin, Erythropoietin, Vaccines, G...
$ 3750
Polio Vaccines Comprehensive Study by Type (IPV (Inactivated Poliovirus Vaccine), OPV (Oral Polio Vaccine)), Application (Hospital, Clinics, Public Services, Others) Players and Region - Global Marke...
$ 3500